Fucoidan- A Seaweed Material that Enhances the Benefits of Heart Surgery

Outcomes for bypass surgery may be improved by the use of seaweed molecules as stated by a new study.

Natural material derived from seaweed may help improve the performance of synthetic vascular grafts used in heart bypass surgery by promoting vascular cell growth and preventing blood clots, as developed and tested at the University of Waterloo.

This is especially important in cases involving small artificial blood vessels - those less than six millimeters in diameter - which are prone to clots that can develop into full blockages. The study, “Fucoidan and topography modification improved in situ endothelialization on acellular synthetic vascular grafts,” has been published in the journal Bioactive Materials.

Coronary Artery Bypass Graft (CABG) - Triple Bypass Surgery
Triple bypass surgery, an open heart surgery involves grafting blood vessels from either the chest or leg onto 3 blocked blood vessels.

‘The effectiveness of synthetic grafts utilized in heart surgery (bypass surgery) may be improved by the use of seaweed molecules.’

Need for Improved Efficacy

“There is a crucial need to develop synthetic vascular graft materials that will increase the rate of long-term functions,” said Dr. Evelyn Yim, a chemical engineering professor and University Research Chair who leads the project.

Researchers added a material called fucoidan, which is made from seaweed, to modify synthetic blood vessels. Fucoidan has a structure similar to that of heparin, a drug used as an anticoagulant.

When applied with a nanotechnology technique known as micropatterning, fucoidan promotes the growth of vascular cells around the inner surface of the graft, significantly reducing the chances of clots forming.

High Body Fat Tied to Four-fold Increase in Death Risk After Heart Bypass Surgery
Death risk is over four times higher in patients who had undergone heart bypass surgery with a high body fat mass, finds a new study

For patients, the potential benefits include fewer complications, a better quality of life, and less risk of the recurrence of blockages requiring additional drug treatment or surgery.

“A functional, off-the-shelf, small-diameter vascular graft will help save lives,” said Yim, director of the Regenerative Nanomedicine Lab at Waterloo. “What’s important is that they will be much longer-lasting and allow blood to flow freely.”

Once in a Lifetime: A 98-year-old Iraqi Man Undergoes Bypass Surgery In India
A 98-Year-Old Iraqi man had Undergone a four in one bypass Heart Surgery in Gurugram recently. The surgery was performed by cardiac surgeons from medanta hospital.

The Bypass Surgery

Bypass surgery is performed to restore blood flow to areas of the heart when vessels become blocked. Vessels harvested from the patient are the gold standard for grafts, but limited availability often requires the use of artificial vessels.

In addition to heart bypass surgery, grafts are used in medical procedures to treat vascular diseases and restore blood flow to vital organs and tissues, including the brain and legs.

When synthetic graft material doesn’t allow vascular cells to grow on the inside of an artery or vessel, there is a high chance of clots, which can develop into full blockages or cause inflammation that restricts blood flow.

Yim has successfully tested the new technique using fucoidan and micropatterning on small animals and plans to expand to large animal testing before advancing to clinical trials.

Several researchers from the University of Waterloo's Department of Chemical Engineering and the Oregon Health and Science University's Department of Biomedical Engineering worked together on this project.

Source-Eurekalert